URMC / Labs / Carpizo Lab / Publications

Publications

1. Casabianca A
2. Bellina M
3. Dudgeon C
4. Nezhad MS
5. Harris C
6. Fiore S
7. Bernet A
8. Narrow W
9. Prela O
10. Wang L
11. Astsaturov I
12. Mehlen P
13. Carpizo DR
Protocol for isolating extracellular vesicles from pancreatic cancer cells for liver metastatic niche research.; STAR protocols; Vol 5(3), pp. 103256. 2024 Aug 13.
1. Ajay PS
2. NeMoyer R
3. Goyal S
4. Switchenko JM
5. Lin Y
6. Jabbour SK
7. Carpizo DR
8. Paulos CM
9. Kennedy TJ
10. Shah MM
Does non-metastatic gastric cancer of the cardia warrant a different treatment strategy?; Journal of surgical oncology. 2023 Apr 10.
1. Ajay PS
2. Rajamanickam RK
3. Rhee K
4. NeMoyer R
5. Goyal S
6. Switchenko JM
7. Lin Y
8. Jabbour SK
9. Carpizo DR
10. Kennedy TJ
11. Shah MM
Identifying the optimal treatment strategy in patients with resectable non-cardia gastric cancer.; Surgical endoscopy. 2023 Jan 07.
1. Ladner DP
2. Goldstein AM
3. Billiar TR
4. Cameron AM
5. Carpizo DR
6. Chu DI
7. Coopersmith CM
8. DeMatteo RP
9. Feng SH
10. Gallagher KA
11. Gillanders WE
12. Lal BK
13. Lipshutz GS
14. Liu A
15. Maier RV
16. Mittendorf EA
17. Morris AM
18. Sicklick JK
19. Velazquez OC
20. Whitson BA
21. Wilke LG
22. Yoon SS
23. Zeiger MA
24. Farmer DL
25. Hwang ES
Transforming the Future of Surgeon-Scientists.; Annals of surgery. 2023 Jan 02.
1. Dudgeon C
2. Casabianca A
3. Harris C
4. Ogier C
5. Bellina M
6. Fiore S
7. Bernet A
8. Ducarouoge B
9. Goldschneider D
10. Su X
11. Pitarresi J
12. Hezel A
13. De S
14. Narrow W
15. Soliman F
16. Shields C
17. Vendramini-Costa DB
18. Prela O
19. Wang L
20. Astsaturov I
21. Mehlen P
22. Carpizo DR
Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling.; Cell reports; Vol 42(11), pp. 113369. 2023 Jan 02.
1. Ghaddar B
2. Biswas A
3. Harris C
4. Omary MB
5. Carpizo DR
6. Blaser MJ
7. De S
Tumor microbiome links cellular programs and immunity in pancreatic cancer.; Cancer cell; Vol 40(10), pp. 1240-1253.e5. 2022 Oct 10.
1. Melucci AD
2. Chacon AC
3. Burchard PR
4. Tsagkalidis V
5. Casabianca AS
6. Goyal S
7. Switchenko JM
8. Kooby DA
9. Staley CA
10. Carpizo DR
11. Shah MM
The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer.; Annals of surgical oncology. 2022 Sep 19.
1. Melucci AD
2. Carpizo DR
3. Shah MM
ASO Author Reflections: Pretreatment CA 19-9 Threshold of 98 U/mL is a Reasonable Cutoff for Prognostication of Clinical Stage I and II Pancreatic Cancer.; Annals of surgical oncology. 2022 Sep 10.
1. Melucci AD
2. Chacon AC
3. Burchard PR
4. Tsagkalidis V
5. Casabianca AS
6. Goyal S
7. Switchenko JM
8. Kooby DA
9. Staley CA
10. Carpizo DR
11. Shah MM
ASO Visual Abstract: The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer.; Annals of surgical oncology. 2022 Sep 10.
1. Ajay PS
2. Casabianca A
3. Shah MM
4. Carpizo DR
Reply to: Radical treatment for stage IV gallbladder cancers: Is surgery a worthwhile exercise in advanced cancers?; European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2022 Aug 27.
1. Ajay PS
2. Tsagkalidis V
3. Casabianca A
4. Burchard PR
5. Melucci AD
6. Chacon A
7. Goyal S
8. Switchenko JM
9. Kooby DA
10. Carpizo DR
11. Shah MM
A review of hepatic epithelioid hemangioendothelioma-Analyzing patient characteristics and treatment strategies.; Journal of surgical oncology. 2022 Aug 17.
1. Casabianca AS
2. Tsagkalidis V
3. Burchard PR
4. Chacon A
5. Melucci A
6. Reitz A
7. Swift DA
8. McCook AA
9. Switchenko JM
10. Shah MM
11. Carpizo DR
Surgery in combination with systemic chemotherapy is associated with improved survival in stage IV gallbladder cancer.; European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2022 Jun 22.
1. Casabianca AS
2. Hernandez Caballero AI
3. Thornburg LL
4. Carpizo D
Management of hepatic haemangioma in pregnancy.; BMJ case reports; Vol 15(6). 2022 Jun 10.
1. Greco SH
2. Chao JC
3. Heath NG
4. Lin Y
5. Gall VA
6. Grandhi MS
7. Kennedy TJ
8. Carpizo DR
9. Alexander HR
10. Langan RC
11. August DA
Surgery is Associated With Improved Overall Survival in Patients With Metastatic Gastric Cancer: A National Cancer Database Analysis.; The American surgeon. 2022 Jun 01.
1. Burchard PR
2. Dave YA
3. Loria AP
4. Parikh NB
5. Pineda-Solis K
6. Ruffolo LI
7. Strawderman M
8. Schoeniger LO
9. Galka E
10. Tomiyama K
11. Orloff MS
12. Carpizo DR
13. Linehan DC
14. Hernandez-Alejandro R
Early postoperative ERAS compliance predicts decreased length of stay and complications following liver resection.; HPB : the official journal of the International Hepato Pancreato Biliary Association. 2022 Jan 25.
1. Burchard PR
2. Chacon AC
3. Melucci A
4. Casabianca AS
5. Goyal S
6. Switchenko JM
7. Maithel SK
8. Kooby DA
9. Carpizo DR
10. Shah MM
Defining the role of systemic therapy in resectable pancreatic acinar cell carcinoma.; Journal of surgical oncology. 2022 Jan 07.
1. Ha JH
2. Prela O
3. Carpizo DR
4. Loh SN
p53 and Zinc: A Malleable Relationship.; Frontiers in molecular biosciences; Vol 9. 2022.
1. Ha JH
2. Yu X
3. Carpizo DR
4. Loh SN
Urea Denaturation, Zinc Binding, and DNA Binding Assays of Mutant p53 DNA-binding Domains and Full-length Proteins.; Bio-protocol; Vol 11(20). 2021 Oct 20.
1. Carpizo DR
2. Harris CR
Genetic Drivers of Ileal Neuroendocrine Tumors.; Cancers; Vol 13(20). 2021 Oct 10.
1. Ciner AT
2. Hochster HS
3. August DA
4. Carpizo DR
5. Spencer KR
Delayed cytokine release syndrome after neoadjuvant nivolumab: a case report and literature review.; Immunotherapy. 2021 Jul 21.
1. Gilleran JA
2. Yu X
3. Blayney AJ
4. Bencivenga AF
5. Na B
6. Augeri DJ
7. Blanden AR
8. Kimball SD
9. Loh SN
10. Roberge JY
11. Carpizo DR
Benzothiazolyl and Benzoxazoyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53.; Journal of medicinal chemistry. 2021 Feb 04.
1. Meltzer RS
2. Kooby DA
3. Switchenko JM
4. Datta J
5. Carpizo DR
6. Maithel SK
7. Shah MM
ASO Visual Abstract: Does Major Pancreatic Surgery have Utility for Nonagenarians with Pancreas Cancer?; Annals of surgical oncology. 2021 Jan 07.
1. Greco SH
2. August DA
3. Shah MM
4. Chen C
5. Moore DF
6. Masanam M
7. Turner AL
8. Jabbour SK
9. Javidian P
10. Grandhi MS
11. Kennedy TJ
12. Alexander HR
13. Carpizo DR
14. Langan RC
Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database.; Surgery open science; Vol 3. 2021 Jan.
1. Blanden AR
2. Yu X
3. Blayney AJ
4. Demas C
5. Ha JH
6. Liu Y
7. Withers T
8. Carpizo DR
9. Loh SN
Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants.; eLife; Vol 9. 2020 Dec 02.
1. Meltzer RS
2. Kooby DA
3. Switchenko JM
4. Datta J
5. Carpizo DR
6. Maithel SK
7. Shah MM
Does Major Pancreatic Surgery Have Utility in Nonagenarians with Pancreas Cancer?; Annals of surgical oncology. 2020 Nov 03.
1. Muaddi H
2. D'Angelica M
3. Wiseman JT
4. Dillhoff M
5. Latchana N
6. Roke R
7. Ko YJ
8. Carpizo D
9. Spencer K
10. Fields RC
11. Williams G
12. Aucejo F
13. Acevedo-Moreno LA
14. Billingsley KG
15. Walker BS
16. Mayo SC
17. Karanicolas PJ
Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.; Journal of surgical oncology. 2020 Oct 23.
1. Park KU
2. Mamounas EP
3. Katz MHG
4. Unzeitig G
5. Carpizo D
6. You YN
7. Francescatti A
8. Hunt KK
9. Boughey JC
Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles.; Annals of surgical oncology; Vol 27(7). 2020 Jul.
1. Kangas-Dick A
2. Gall V
3. Hilden P
4. Turner A
5. Greenbaum A
6. Sesti J
7. Paul S
8. Carpizo D
9. Kennedy T
10. Sadaria Grandhi M
11. Alexander HR
12. Wang S
13. Geffner S
14. August D
15. Langan RC
Disparities in utilization of services for racial and ethnic minorities with hepatocellular carcinoma associated with hepatitis C.; Surgery; Vol 168(1). 2020 Jul.
1. Shah MM
2. Meyer BI
3. Rhee K
4. NeMoyer RE
5. Lin Y
6. Tzeng CD
7. Jabbour SK
8. Kennedy TJ
9. Nosher JL
10. Kooby DA
11. Maithel SK
12. Carpizo DR
Conditional survival analysis of hepatocellular carcinoma.; Journal of surgical oncology. 2020 Jun 10.
1. Shah MM
2. NeMoyer RE
3. Greco SH
4. Chen C
5. Moore DF
6. Grandhi MS
7. Langan RC
8. Kennedy TJ
9. Javidian P
10. Jabbour SK
11. Alexander HR
12. August DA
13. Carpizo DR
Subcategorizing T1 Staging in Pancreatic Adenocarcinoma Predicts Survival in Patients Undergoing Resection: An Analysis of the National Cancer Database.; Journal of pancreatic cancer; Vol 6(1). 2020.
1. Khullar K
2. Patel NM
3. Anderson C
4. Chundury A
5. Carpizo D
6. Feingold D
7. Grandhi M
8. Hochster H
9. Jani K
10. Kennedy T
11. Langan R
12. Spencer K
13. August D
14. Jabbour SK
The Evolving Role of Radiotherapy in Locally Advanced Rectal Cancer and the Potential for Nonoperative Management.; Oncology & hematology review; Vol 16(1). 2020.
1. Contractor T
2. Clausen R
3. Harris G
4. Rosenfeld J
5. Carpizo D
6. Tang L
7. Harris C
IGF2 drives formation of ileal neuroendocrine tumors in patients and mice.; Endocrine-related cancer. 2020 Jan 01.
1. Chi A
2. Adams BE
3. Sesti J
4. Paul S
5. Turner AL
6. August D
7. Carpizo D
8. Kennedy T
9. Grandhi M
10. Alexander HR
11. Libutti SK
12. Geffner S
13. Langan RC
Outcomes Following Major Oncologic Operations for Non-AIDS-Defining Cancers in the HIV Population: A Matched Comparison to the General Population.; World journal of surgery; Vol 43(12). 2019 Dec.
1. Zaman S
2. Yu X
3. Bencivenga AF
4. Blanden AR
5. Liu Y
6. Withers T
7. Na B
8. Blayney AJ
9. Gilleran J
10. Boothman DA
11. Loh SN
12. Kimball SD
13. Carpizo DR
Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding.; Molecular cancer therapeutics; Vol 18(8). 2019 Aug.
1. Ali ND
2. Donohue K
3. Zandieh S
4. Chen C
5. Moore D
6. Poplin E
7. Shah MM
8. Nosher J
9. Gui B
10. Jabbour SK
11. Spencer K
12. Carpizo DR
Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months: A Single Institutional Study.; American journal of clinical oncology; Vol 42(6). 2019 Jun.
1. Hasan O
2. Greco S
3. Kennedy T
4. Carpizo D
5. Kempf J
6. Nosher J
Aberrant arc between the common hepatic artery and a replaced right hepatic artery resulting in misperfusion in a patient with a hepatic arterial infusion pump.; Surgical and radiologic anatomy : SRA; Vol 41(3). 2019 Mar.
1. Dave YA
2. Gupta A
3. Shah MM
4. Carpizo D
Liver haematoma as a presentation of peliosis hepatis.; BMJ case reports; Vol 12(2). 2019 Feb 22.
1. Yu X
2. Carpizo DR
Flipping the "switch" on mutant p53 by zinc metallochaperones: how a brief pulse of zinc can reactivate mutant p53 to kill cancer.; Oncotarget; Vol 10(9). 2019 Jan 29.
1. Na B
2. Yu X
3. Withers T
4. Gilleran J
5. Yao M
6. Foo TK
7. Chen C
8. Moore D
9. Lin Y
10. Kimball SD
11. Xia B
12. Ganesan S
13. Carpizo DR
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation.; NPJ breast cancer; Vol 5. 2019.
1. Sayan M
2. Yegya-Raman N
3. Greco SH
4. Gui B
5. Zhang A
6. Chundury A
7. Grandhi MS
8. Hochster HS
9. Kennedy TJ
10. Langan RC
11. Malhotra U
12. Rustgi VK
13. Shah MM
14. Spencer KR
15. Carpizo DR
16. Nosher JL
17. Jabbour SK
Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes.; Frontiers in oncology; Vol 9. 2019.
1. Langan RC
2. Carpizo DR
Modernizing the clinical risk score to more accurately predict survival following resection of colorectal liver metastases.; Translational gastroenterology and hepatology; Vol 4. 2019.
1. Yu X
2. Kogan S
3. Chen Y
4. Tsang AT
5. Withers T
6. Lin H
7. Gilleran J
8. Buckley B
9. Moore D
10. Bertino J
11. Chan C
12. Kimball SD
13. Loh SN
14. Carpizo DR
Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics.; Clinical cancer research : an official journal of the American Association for Cancer Research; Vol 24(18). 2018 Sep 15.
1. Gui B
2. Weiner AA
3. Nosher J
4. Lu SE
5. Foltz GM
6. Hasan O
7. Kim SK
8. Gendel V
9. Mani NB
10. Carpizo DR
11. Saad NE
12. Kennedy TJ
13. Zuckerman DA
14. Olsen JR
15. Parikh PJ
16. Jabbour SK
Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization.; American journal of clinical oncology; Vol 41(9). 2018 Sep.
1. Yegya-Raman N
2. Shah MM
3. Grandhi MS
4. Poplin E
5. August DA
6. Kennedy TJ
7. Malhotra U
8. Spencer KR
9. Carpizo DR
10. Jabbour SK
Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma.; Annals of pancreatic cancer; Vol 1. 2018 Aug.
1. Weiner AA
2. Gui B
3. Newman NB
4. Nosher JL
5. Yousseff F
6. Lu SE
7. Foltz GM
8. Carpizo D
9. Lowenthal J
10. Zuckerman DA
11. Benson B
12. Olsen JR
13. Jabbour SK
14. Parikh PJ
Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases.; Journal of vascular and interventional radiology : JVIR; Vol 29(8). 2018 Aug.
1. Casabianca AS
2. Shah MM
3. Carpizo D
Accessory bile duct: a rare but important anatomical variant.; BMJ case reports; Vol 2018. 2018 Jun 17.
1. Kogan S
2. Carpizo DR
Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics.; Cancers; Vol 10(6). 2018 May 29.
1. Shimada K
2. Reznik E
3. Stokes ME
4. Krishnamoorthy L
5. Bos PH
6. Song Y
7. Quartararo CE
8. Pagano NC
9. Carpizo DR
10. deCarvalho AC
11. Lo DC
12. Stockwell BR
Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells.; Cell chemical biology; Vol 25(5). 2018 May 17.
1. NeMoyer RE
2. Shah MM
3. Hasan O
4. Nosher JL
5. Carpizo DR
A novel combined interventional radiologic and hepatobiliary surgical approach to a complex traumatic hilar biliary stricture.; International journal of surgery case reports; Vol 44. 2018.
1. Tsang AT
2. Dudgeon C
3. Yi L
4. Yu X
5. Goraczniak R
6. Donohue K
7. Kogan S
8. Brenneman MA
9. Ho ES
10. Gunderson SI
11. Carpizo DR
U1 Adaptors Suppress the KRAS-MYC Oncogenic Axis in Human Pancreatic Cancer Xenografts.; Molecular cancer therapeutics; Vol 16(8). 2017 Aug.